Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04055844
Title Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 United States Details
Washington University Medical School Saint Louis Missouri 63130 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field